Articles by Disease (Non Hodgkin's Lymphoma)

Long Term Prognosis in IgG4-Related Systemic Disease (ISD)

Journal: Current Immunology Reviews (Discontinued)
Volume: 7
Page: 239-245
Author(s): Raghuwansh P. Sah and Suresh T. Chari

Development of Patents and Clinical Trials on Regenerative Therapy: Gene Therapy

Journal: Recent Patents on Regenerative Medicine
Volume: 1
Page: 182-194
Author(s): Jose Prados, Houria Boulaiz, Pablo J. Alvarez, Consolacion Melguizo, Fernando Rodriguez-Serrano, Juan A. Marchal, Macarena Peran, Octavio Caba, Fidel Hita and Antonia Aranega

Perspectives in Nanomedicine-Based Research Towards Cancer Therapies

Journal: Current Nanoscience
Volume: 7
Page: 142-152
Author(s): Yogesh M. Rane and Eliana B. Souto

Epigenetically - Targeted Therapies for the Treatment of Hematological Malignancies

Journal: Current Medicinal Chemistry
Volume: 18
Page: 1757-1764
Author(s): E. Georgiou and S. Kouidou

Recent Advances in Copper Radiopharmaceuticals

Journal: Current Radiopharmaceuticals
Volume: 4
Page: 109-121
Author(s): Guiyang Hao, Ajay N. Singh, Orhan K. Oz and Xiankai Sun

Interferon-α Treatment in Systemic Mastocytosis

Journal: Current Drug Targets
Volume: 12
Page: 433-436
Author(s): Ole Weis Bjerrum

Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives

Journal: Current Cancer Drug Targets
Volume: 11
Page: 239-253
Author(s): D. Chen, M. Frezza, S. Schmitt, J. Kanwar and Q. P. Dou

Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials

Journal: Current Cancer Drug Targets
Volume: 11
Page: 254-284
Author(s): G. K. Lloyd, M. A. Palladino, A. Younes, E. Valashi, M. A. Spear, C. M. Sloss, A. M. Roccaro, P. G. Richardson, F. Pajonk, H. Ovaa, Y. Oki, S. T.C. Neuteboom, C. P. Miller, D. J. McConkey, W. McBride, B. C. Potts, K. S. Lam, P. R. Jensen, M. Groll, I. M. Ghobrial, W. Fenical, J. C. Cusack, D. Chauhan, J. Chandra, B. Bonavida, C. Berkers, S. Baritaki, K. C. Anderson and M. X. Albitar

Second Generation Proteasome Inhibitors: Carfilzomib and Immunoproteasome-Specific Inhibitors (IPSIs)

Journal: Current Cancer Drug Targets
Volume: 11
Page: 285-295
Author(s): D. J. Kuhn, R. Z. Orlowski and C. C. Bjorklund

Pathobiology and Prevention of Cancer Chemotherapy-Induced Bone Growth Arrest, Bone Loss, and Osteonecrosis

Journal: Current Molecular Medicine
Volume: 11
Page: 140-151
Author(s): C. Fan, B. K. Foster, W. H. Wallace and C. J. Xian